Assessment of the Pro-Arrhythmic Potential of Anti-Arrhythmic Drugs: An Experimental Approach
- 1 March 2001
- journal article
- other
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 6 (1) , 89-97
- https://doi.org/10.1177/107424840100600109
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Proarrhythmia of Azimilide and Other Class III Antiarrhythmic Agents in the Adrenergically Stimulated RabbitProceedings of the Society for Experimental Biology and Medicine, 2000
- Drug-Related Torsades de Pointes in the Isolated Rabbit HeartJournal of Cardiovascular Pharmacology, 1998
- Polymorphic ventricular tachycardias induced by ?-sotalol and phenylephrine in canine preparations of atrioventricular block: initiation in the conduction system followed by spatially unstable re-entryCardiovascular Research, 1998
- The Effect of Flunarizine and Ryanodine on Acquired Torsades de Pointes Arrhythmias in the Intact Canine HeartJournal of Cardiovascular Electrophysiology, 1995
- Methods and limitations of an experimental model of long QT syndromeJournal of Pharmacological Methods, 1991
- QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the RabbitJournal of Cardiovascular Pharmacology, 1990
- Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary deathAmerican Heart Journal, 1985
- Torsade de pointes due to quinidine: Observations in 31 patientsAmerican Heart Journal, 1984
- A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient.Circulation, 1984
- Torsade de pointes: The long-short initiating sequence and other clinical features: observations in 32 patientsJournal of the American College of Cardiology, 1983